FGEN
FibroGen Inc
Price:  
1.23 
USD
Volume:  
1,644,234.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

FGEN WACC - Weighted Average Cost of Capital

The WACC of FibroGen Inc (FGEN) is 8.4%.

The Cost of Equity of FibroGen Inc (FGEN) is 10.50%.
The Cost of Debt of FibroGen Inc (FGEN) is 5.50%.

Range Selected
Cost of equity 7.70% - 13.30% 10.50%
Tax rate 0.10% - 0.20% 0.15%
Cost of debt 4.00% - 7.00% 5.50%
WACC 6.1% - 10.6% 8.4%
WACC

FGEN WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.84 1.51
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.70% 13.30%
Tax rate 0.10% 0.20%
Debt/Equity ratio 0.75 0.75
Cost of debt 4.00% 7.00%
After-tax WACC 6.1% 10.6%
Selected WACC 8.4%